OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.

OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.

We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor. 


Archiving: full-text archived in CLOCKSS.

Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2021, 1-2 days of FREE language polishing time is also included in this period).

Current Issue: 2022  Archive: 2021 2020 2019 2018 2017

Special Issue

Research on Xenotransplantation

Submission Deadline: November 30, 2021 (Open) Submit Now

Guest Editor

Suzanne Bertera, PhD

Institute of Cellular Therapeutics, Allegheny-Singer Research Institute, Allegheny Health Network, South Tower, 320 East North Avenue, Pittsburgh, PA 15212-4772, USA

Tel: 412-359-4758

Website | E-Mail

Research Interests: Diabetes research; islet isolation and transplantation; islet xenotransplantation; cell transplantation; gene therapy

About This Topic

This special issue focuses on xenotransplantation of tissues, cells, and organs. Xenotransplantation is widely seen as one of the options available to narrow the gap between human organ donors and demand for organs for transplantation. Advancements in understanding the mechanisms of xeno-rejection, improved immunosuppressive options, and easier methods of genetic manipulation of potential pig organ donors have helped bring xenotransplantation from the realm of science fiction to the dawn of a clinical age. Pig tissues such as heart valves are already transplanted into patients, clinical trials of porcine corneas and islet cells have been undertaken, and preliminary data suggests the first clinical trials of kidney and heart may soon begin. Authors are invited to submit reviews and commentaries or original data for peer review. This issue is intended as a single source to provide up to date knowledge and opinion on xenotransplantation. Topics may include the advantages and limitations of using various animal models, preliminary data on organ or cellular cross-species transplantation, immunology, methods of animal cloning or genetic manipulation, public opinion and ethics of xenotransplantation, or any topic relevant to the field.